When To Start Thinking About The Use Of Automation

In this segment from the Cell & Gene Live event Considerations For Investing In Your Gene Therapy’s Automation Framework, TJ Cradick, Ph.D., CSO of Excision BioTherapeutics, and Matt Humes, head of lab automation at Beam Therapeutics, discuss when you should start thinking about the use of automation in your operations. More importantly, they talk about the key questions to ask when building your company’s automation framework.